| Recruiting | Impact of Optimized Recruitment and Follow-up of Patients With Pseudoxanthoma Elasticum (PXE) NCT06636344 | University Hospital, Angers | — |
| Not Yet Recruiting | Purinergic Compounds in Pseudoxanthoma Elasticum NCT07323082 | Centre Hospitalier Universitaire de Nice | N/A |
| Recruiting | CHOPXE - Analysis of Choriocapillaris Flow Deficits in Patients With Pseudoxanthoma Elasticum NCT07006649 | University Hospital, Angers | N/A |
| Recruiting | Progression Assessment of PXE-associated Alterations NCT07048106 | University Hospital, Bonn | — |
| Recruiting | ADAPT Study: Long-term Safety Study of INZ-701 in Patients With ENPP1 Deficiency and ABCC6 Deficiency NCT06462547 | Inozyme Pharma | Phase 2 |
| Recruiting | The ENERGY Study: Evaluation of Safety and Tolerability of INZ-701 in Infants With ENPP1 Deficiency or ABCC6 D NCT05734196 | Inozyme Pharma | Phase 1 |
| Recruiting | The Prevention of Systemic Ectopic Mineralization in Pseudoxanthoma Elasticum NCT05832580 | UMC Utrecht | Phase 3 |
| Recruiting | PPI Supplementation to Fight ECtopIc Calcification in PXE NCT04868578 | Centre Hospitalier Universitaire de Nice | N/A |
| Completed | A Study of DS-1211b in Individuals With PseudoXanthoma Elasticum NCT05569252 | Daiichi Sankyo | Phase 2 |
| Active Not Recruiting | Progression Rate of Pseudoxanthoma Elasticum-associated Choroidal and Retinal Degeneration NCT05662085 | University Hospital, Basel, Switzerland | — |
| Completed | Evaluation of Safety, Tolerability, and Efficacy of INZ-701 in Adults With ABCC6 Deficiency Causing PXE NCT05030831 | Inozyme Pharma | Phase 1 / Phase 2 |
| Completed | Employment of Patients With Pseudoxanthoma Elasticum NCT05246189 | University Hospital, Angers | — |
| Completed | Pseudoxanthoma Elasticum (PXE) Natural History Biomarkers in PXE Individuals and Their Biological Non-PXE Sibl NCT05025722 | Daiichi Sankyo | — |
| Withdrawn | Oral Pyrophosphate Absorption in PXE Disease NCT04441671 | Tampere University Hospital | Phase 2 |
| Unknown | Intestinal Microbiota and Vitamin K Levels in PXE Patients (IMPROVE Study) NCT03813550 | University Hospital, Angers | N/A |
| Unknown | Natural History of GACI With or Without ARHR2 or PXE NCT03758534 | Universität Münster | — |
| Unknown | Biological Collection of Kidney Cells NCT03364504 | University Hospital, Angers | N/A |
| Completed | What's Happen Under the Calcification Process in Pseudoxanthoma Elasticum NCT03070860 | University Hospital, Angers | N/A |
| Completed | Intravitreal Aflibercept for Therapy of Patients With Pseudoxanthoma Elasticum (PXE) NCT02537054 | University Hospital, Bonn | Phase 2 |
| Unknown | Characterization of Pseudoxanthoma Elasticum NCT02108392 | University Hospital, Bonn | — |
| Completed | Magnesium Supplements In The Treatment Of Pseudoxanthoma Elasticum (PXE) NCT01525875 | Mark Lebwohl | Phase 2 |
| Unknown | Arterial Wall Calcium Load in Pseudoxanthoma Elasticum NCT01731080 | University Hospital, Angers | — |
| Completed | Functional and Structural Characterization of Arteriopathy in Pseudoxanthoma Elasticum (PXE) NCT01446393 | University Hospital, Angers | — |
| Unknown | Phenotypic Expressions in a French Pseudoxanthoma-Elasticum Cohort NCT01446380 | University Hospital, Angers | — |
| Completed | Treatment of Exudative and Vasogenic Chorioretinal Diseases Including Variants of AMD and Other CNV Related Ma NCT00470977 | Manhattan Eye, Ear & Throat Hospital | Phase 1 / Phase 2 |
| Completed | Genetic Analysis of Patients With Pseudoxanthoma Elasticum NCT00341419 | National Cancer Institute (NCI) | — |
| Completed | Evolution of Visual Impairment During Pseudoxanthoma Elasticum NCT00555113 | European Georges Pompidou Hospital | — |